OMER FY 2024 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$835M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$169M

Net Income

-$157M

EPS (Diluted)

$-2.70

Cash Flow

Operating Cash Flow

-$149M

Free Cash Flow

-$149M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$277M

Total Liabilities

$460M

Stockholders' Equity

-$183M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$169M	-$165M	-2.9%
Net Income	-$157M	-$118M	-33.1%